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THE ROLE OF FIBEROPTIC BRONCHOSCOPY IN EVALUATING   
THE CAUSES OF UNDIAGNOSED PLEURAL EFFUSION 
                                                                                                               
BACKGROUND:                                                                      
The role of Fiberoptic bronchoscopy in the investigation of pleural 
effusion is not well defined. Although the inclusion of bronchoscopy 
as a part of routine evaluation of all such patients is frequently 
advocated, evidence to support this is sparse. 
In an attempt to clarify the role of Fiberoptic bronchoscopy in 
the investigation of undiagnosed pleural effusion a study was  
conducted to evaluate the diagnostic merits of Fiberoptic 
bronchoscopy .                                                                                                                                                                  
AIMS AND OBJECTIVES:  
To evaluate the diagnostic merit of Fiberoptic bronchoscopy in 
evaluating the causes of undiagnosed pleural effusion. 
MATERIALS AND METHODS:  An observational study 
involving 110 individuals,  both males and females, coming to the 
outpatient department of Institute of Thoracic medicine & Madras 
Medical College, with diagnosis of pleural effusion, between January 
and September 2011.All eligible and consenting patients were 
subjected to  routine investigations and pleural fluid analysis. In 
patients who had exudative pleural effusion and initial investigations 
were inconclusive, Pleural biopsy and Fiberoptic bronchoscopy were 
done  and specimens were sent for microbiological, cytological and 
histopathological analysis. 
RESULTS: 
Among 110 patients with pleural effusion, after initial work up, 
diagnosis was made in 43 (39.09%)patients. In the remaining 67 
patients, 3 patients were not willing for bronchoscopy. Out of 64 
patients whose diagnosis was not made by initial work up, FOB was 
useful in making diagnosis in 18 (28.1%) cases. Pleural biopsy helped 
in diagnosing 26 (40.62%) cases. 
     CONCLUSION: 
        Fiberoptic bronchoscopy is useful in patients with exudative 
effusion still undiagnosed after pleural fluid cytology and biopsy and 
with parenchymal abnormalities on chest skiagram or with 
hemoptysis.                                                                                         
INTRODUCTION
Pleural effusion is an abnormal collection of fluid in the pleural
space. It is not a disease but rather a complication of an underlying
illness. Effusion can occur for a variety of reasons. Common
classification systems divide pleural effusions into two categories of (1)
Transudative pleural effusions and (2) Exudative pleural effusions.
             Determining the cause of a pleural effusion is greatly facilitated
by analysis of the pleural fluid. Thoracentesis is a simple bedside
procedure that permits fluid to be rapidly sampled, visualized, examined
microscopically and quantified. A systematic approach to analysis of the
fluid in conjunction with the clinical presentation should allow the
clinician to diagnose the cause of an effusion.
A definitive diagnosis is provided by the finding of malignant
cells or specific organisms in the pleural fluid can be established in
approximately 25% of patients.
Pleural effusion remains undiagnosed after routine tests in
pleural fluid in many patients. So, we need a simple and safe
investigative tool to evaluate undiagnosed effusion.
2This study is designed to diagnose the cases of undiagnosed
effusions by using Fiberoptic bronchoscope, where pleural fluid analysis
and closed pleural biopsy were inconclusive.
Fiberoptic bronchoscopy is seemed to be justified in the
diagnostic work-up of pleural effusions of unknown origin, since
neoplasm is frequently the cause of a pleural effusion that remains
undiagnosed after analysis of pleural fluid and closed pleural biopsy.
3AIM OF THE STUDY
To evaluate the diagnostic merits of Fiberoptic bronchoscopy in
evaluating the causes of undiagnosed pleural effusion.
4REVIEW OF LITERATURE
INTRODUCTION
Pleural fluid accumulates when pleural fluid formation exceeds
pleural fluid absorption. Normally fluid enters the pleural space from the
capillaries in the parietal pleura and is removed via the lymphatics
situated in the parietal pleura. Fluid can also enter the pleural space from
the interstitial spaces of the lung via visceral pleura or from peritoneal
cavity via small holes in the diaphragm. The lymphatics have the
capacity to absorb 20 times more fluid than is normally formed.
Accordingly, a pleural effusion may develop when there is excess
pleural fluid formation or when there is decreased fluid removal by the
lymphatics.
         When a patient is found to have a pleural effusion, an effort should
be made to determine the cause.
        The first step is to determine whether the effusion is a transudate or
an exudate. Light’s criteria were used to differentiate exudative pleural
effusion from transudative pleural effusion.
5Exudative pleural effusions meet at least one of the following
criteria, whereas transudative pleural effusions meet none:
Pleural fluid protein divided by serum protein greater than 0.5
Pleural fluid LDH divided by serum LDH greater than 0.6
Pleural fluid LDH greater than two thirds of the upper limit of
normal serum LDH.
          A transudative pleural effusion occurs when systemic factors that
influence the formation and absorption of pleural fluid are altered. The
leading causes of transudative pleural effusions are left ventricular
failure and cirrhosis. An exudative pleural effusion occurs when local
factors that influence the formation and absorption of pleural fluid
altered. The leading causes of exudative pleural effusions are
Tuberculosis, bacterial pneumonia, malignancy, viral infection, and
pulmonary embolism. The primary reason to make this differentiation is
that additional diagnostic procedures are indicated with exudative
effusions to define the cause of the local disease.
Thoracentesis for pleural fluid analysis and closed pleural biopsy
are the two fundamental diagnostic procedures in approaching the
underlying entity of a pleural effusion of unknown origin.
6However, a significant number of patients still have no definite
diagnosis after the above methods.
Fiberoptic bronchoscopy is seemed to be justified in the
diagnostic work-up of pleural effusions of unknown origin, since
neoplasm is frequently the cause of a pleural effusion that
remains undiagnosed after analysis of pleural fluid and closed pleural
biopsy(1,2,3).
7COMMON CAUSES OF PLEURAL EFFUSION
TRANSUDATIVE PLEURAL EFFUSIONS
Congestive heart failure
Cirrhosis
Nephrotic syndrome
Superior vena caval obstruction
Urinothorax
Peritoneal dialysis Glomerulonephritis
Myxedema
Hypoalbuminemia
Fontan procedure
Cerebrospinal fluid leaks to pleura
Sarcoidosis
EXUDATIVE PLEURAL EFFUSIONS
Neoplastic diseases
Metastatic disease
8Mesothelioma
Pyothorax-associated lymphoma
Bacterial infections
Tuberculosis
Fungal infections
Parasitic infections
Viral infections
Pulmonary embolization
Gastrointestinal disease
Heart diseases
Obstetric and gynecologic diseases
Collagen vascular diseases
Drug-induced pleural disease
Asbestos exposure
Sarcoidosis
Hemothorax
Chylothorax
9NEEDLE BIOPSY OF THE PLEURA
ABRAM’S NEEDLE
The Abram’s needle consists of three parts: a large outer trocar,
an inner cutting cannula, and an inner solid stylet. The end of outer
trocar is blunt so that the instrument requires one to make a small
scalpel incision in the anesthetized skin and subcutaneous tissue to
permit insertion of the biopsy needle without undue force. This incision
should be made along the lines of cleavage to minimize postoperative
scarring. The inner cutting cannula fits tightly in the outer trocar and can
be locked in one of two positions: (a) a closed position, in which the
inner cannula obstructs the notch on the outer trocar to make the needle
airtight, and (b) an open position, in which the inner cannula is slightly
withdrawn so that the notch on the outer trocar is not occluded. An
indicator knob in the hexagonal grip of the larger outer trocar indicates
the position of the notch in the distal end of the trocar.
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INDICATIONS
A needle biopsy of the pleura is currently recommended when
tuberculous pleuritis is suspected and the pleural fluid ADA or
interferon-gamma levels are not suspected but the pleural fluid cytology
is negative and thoracoscopy is not readily available.
     With a needle biopsy of the pleura, a small piece of the parietal
pleura is obtained for microscopic or microbiologic evaluation. The
main diagnoses established with a needle biopsy of the pleura are
tuberculous pleuritis and malignancy of the pleura. Currently, needle
biopsy of the pleura is used less than in the past because the diagnosis of
tuberculous pleuritis can be made by measuring the adenosine
deaminase (ADA) or interferon-gamma level in the pleural fluid, and the
diagnosis of pleural malignancy is usually established by pleural fluid
cytology or thoracoscopy (4).
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CONTRAINDICATIONS
The main contraindication to a pleural biopsy is a bleeding
diathesis.
         Another contraindication to needle biopsies is the presence of an
empyema (5). Other contraindications include an uncooperative patient
and local cutaneous lesions such as pyoderma or herpes zoster infection.
A pleural biopsy should not be performed in patients who are
taking anticoagulants or whose bleeding parameters are prolonged.  If
the platelet count is below 50,000/mm3, platelet transfusion should be
given before the procedure is attempted.
If the patient has borderline respiratory failure, one should
hesitate to perform a pleural biopsy because the production of a
pneumothorax could precipitate respiratory failure.
12
TECHNIQUE
            When there is a moderate or larger pleural effusion, the biopsy is
usually done without image guidance. If the effusion is small or
loculated, then either ultrasound or computed tomography (CT) can
accurately identify the location of the fluid. Ultrasound is the preferred
technique for guiding biopsy because it offers the advantage of a rea
time approach to the biopsy and has the added advantages of the absence
of ionizing radiation, portability, ready availability and low expense.
Because the patient can be imaged in the erect position, the depth of the
fluid is maximized, thereby minimizing complications (6).
         The patient is positioned, and the site is selected as for diagnostic
thoracentesis. The skin is cleaned, and the local anesthetic is
administered as for diagnostic thoracentesis. Liberal amounts of
lidocaine should be injected once the rib is passed to ensure adequate
anesthesia of the parietal pleura. In general, if no fluid is obtained with t
he local anesthetic, biopsy should not be attempted. When pleural fluid
has been obtained with the lidocaine syringe and needle, a pleural
biopsy can be performed with an Abram’s needle. A biopsy is
sometimes attempted without free pleural fluid. If there is no fluid, the
procedure should be performed with ultrasonic or CT guidance.
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COMPLICATIONS
Pleural biopsy has the same complications as diagnostic
thoracentesis. One might expect pneumothorax to be more common with
pleural biopsy than with thoracentesis for two reasons. First, the
atmosphere has much more opportunity to be in communication with the
pleural space with the biopsy. Second, when the biopsy specimen is
obtained, the visceral pleura may be inadvertently incised, leaving a
small bronchopleural fistula that can lead to a large pneumothorax.
However, the incidence of pnumothorax and the requirement for tube
thoracostomy are comparable after thoracentesis and pleural biopsy
(7).This is probably because more experienced individuals usually
perform the pleural biopsy.
The second major complication of pleural biopsy is bleeding.
If an intercostals artery or vein is inadvertently biopsied, a hemothorax
can result (8,9).There is one case report of an arteriovenous fistula from
an intercostals artery to an intercostals vein developing after pleural
biopsy (10).
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FIBEROPTIC BRONCHOSCOPY
Since its introduction in 1966 by Ikeda, the flexible bronchoscope
has been widely applied to investigate a variety of bronchopulmonary
disorders.
The role of fiberoptic bronchoscopy in the investigation of
patients who present with a pleural effusion is not well defined.
Although the inclusion of bronchoscopy as a part of routine evaluation
of all such patients is frequently advocated, evidence to support this is
sparse.
Fiberoptic bronchoscopy seems justified in managing unknown
pleural effusions based on following reasons:
Bronchogenic carcinoma is the most common neoplasm that
causes a pleural effusion (11,12,13).
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Diagnostic yield of pleural fluid cytologic findings or closed
pleural biopsy is often unsatisfactory (14,15,16,17).
Before planning of effective management in patients with
massive pleural effusions caused by malignancy,
bronchogenic carcinoma of a central bronchus, should be
excluded first.
INDICATIONS
DIAGNOSTIC
Malignancy
                Diagnosis of bronchogenic carcinoma
                Staging of bronchogenic carcinoma
                Abnormal sputum cytology
          Follow up after treatment of carcinoma
Mediastinal mass
Infection
                Recurrent or unresolved pneumonia
                Infiltrate in immunocompromised patient
               Cavitary lesion
16
Unexplained lung collapse
Interstitial lung disease
Unexplained pleural effusion
Unexplained chronic cough
Hemoptysis
Endotracheal intubation
Tracheo bronchial stricture and stenosis
THERAPEUTIC
Pulmonary toilet
Removal foreign bodies
Insertion of endotrachel tube
Tamponade for bleeding
Drainage of abscess
Stent placement
Bronchoalveolar lavage
17
Aspiration of mediastinal and bronchogenic cysts
Lobar collapse
CONTRAINDICATIONS
Un cooperative patient
Refractory hypoxemia
Unstable cardiac status
Bleeding diathesis
Poorly controlled asthma
Uremia
Hypercarbia
COMPLICATIONS
Intraoperative hypoxemia is the most common complication of
fiberoptic bronchoscopy. It results from partial airway obstruction from
a bronchoscope that is too large, atelectasis due to continuous suctioning
from the side port of bronchoscope. Arrhythmias are often associated
with severe hypoxemia. The two most important complications of
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transbronchial lung biopsy are hemorrhage and pneumothorax. Other
complications include laryngospasm, vomiting with associated
pulmonary aspiration.
TUBERCULOUS PLEURAL EFFUSION
When a tuberculous pleural effusion occurs in the absebce of
radiologically apparent TB, it may be the sequel to a primary infection
6 to 12 weeks previously or it may represent reactivation TB (18).
In industrialized countries, more pleural effusions may be due to
reactivation than are due to post primary infection (18). However,
in a recent study from San Francisco, pleural TB cases were
approximately two times more likely to be clustered than were
pulmonary TB and three times more likely to be clustered than non
respiratory TB cases(19).
           The tuberculous pleural effusion is thought to result from rupture
of a subpleural caseous focus in the lung into pleural space (20).
Supporting evidence comes from the operative findings of Stead et al
(21), who reported that they could demonstrate a caseous tuberculous
focus in the lung contiguous with the diseased pleura in 12 to 15 patients
with tuberculous pleuritis. The remaining three patients in this series
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were found to have parenchymal TB, although these patients did not
have caseous foci adjacent the pleura.
It appears that delayed hypersensitivity plays a large role in the
pathogenesis of tuberculous pleural effusion. The hypersensitivity
reaction is initiated when tuberculous protein gains access to the pleural
space.
        It is probable that delayed hypersensitivity also plays a large role
in the development of tuberculous pleural effusions in humans. The
mycobacterial cultures of the pleural fluid from most patients with
tuberculous pleural effusions are negative (22,23).
Although delayed hypersensitivity to tuberculous protein is
probably responsible for most clinical manifestations of tuberculous
pleuritis, many patients when first evaluated have a negative PPD skin
test. The explanation for this paradox may be a combination of two
factors. First, in some (24), but not in all (25) patients with  tuberculous
pleuritis, a circulating mononuclear adherent cell suppresses the
specifically sensitized circulating T lymphocytes in the peripheral blood.
Second, there may be a sequestration of PPD-reactive T lymphocytes in
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the pleural space involving both Leu-2(suppressor/cytotoxic) and Leu-
3(helper) positive T cells (25).
MALIGNANT PLEURAL EFFUSION
Carcinomas of the lung and breast and lymphomas account for
approximately 75% of malignant plural effusions. Lung cancer is the
leading cause of malignant pleural effusion (26). When patients with
lung cancer are first evaluated, approximately 15% have a pleural
effusion (27).
        Because pleural effusions of unknown origin are frequently caused
by malignant tumor, especially bronchogenic carcinoma, fiberoptic
bronchoscopy is of value in the diagnostic work-up of a pleural effusion
of unknown origin and can be performed to make a diagnosis of
malignancy or other entities particularly in those patients who have
hemoptysis or concurrent parenchymal infiltrates in the chest x- ray
films (28).
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ADENOCARCINOMA
Adenocarcinoma of the lung is a form of non-small cell lung
cancer. Eighty percent of lung cancers are non-small cell cancers, and of
these, about 50% are adenocarcinomas. Adenocarcinoma of the lung
begins in the outer parts of the lung, and it can be present for a long time
before it is diagnosed. It is the type of lung cancer most commonly seen
in women and is often seen in non-smokers. The most common type of
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lung cancer in lifelong non-smokers is the adenocarcinoma. This cancer
usually is seen peripherally in the lungs, as opposed to small cell lung
cancer and squamous cell lung cancer, which both tend to be more
centrally located. The adenocarcinoma has an increased incidence in
smokers, but is also the most common type of lung cancer seen in non-
smokers.
       Adenocarcinoma of the lung tends to stain mucin positive as it is
derived from the mucus producing glands of the lungs. Similar to other
adenocarcinoma, if the tumor is well differentiated (low grading) it will
resemble the normal glandular structure. Poorly differentiated
adenocarcinoma will not resemble the normal glands (high grade) and
will be detected by seeing that they stain positive for mucin (which the
glands produce).
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SQUAMOUS CELL CARCINOMA
Squamous cell lung cancer is a form of non-small cell lung cancer.
Squamous cell lung cancers usually begin in the bronchial tubes (large
airways) in the central part of the lungs.
Squamous cell carcinoma cells are large, flattened and stratified
with a high cytoplasm to nucleus ratio. Key diagnostic features include
the presence of intracytoplasmic keratin which may be linked to the
presence of intercellular bridges and squamous pearl formation. Most
24
squamous cell carcinomas arise centrally within the main, lobar,
segmental or subsegmental bronchi but some occur more peripherally.
The tumor mass generally extends into the lumen of the airway with
invasion into the underlying wall.
SMALL CELL LUNG CARCINOMA
        Small cell lung cancer (SCLC) is a tumor of extremes. Untreated, it
is one of the most highly virulent malignancies known, with a life
expectancy best measured in days to weeks. On the other hand, it
displays exquisite chemosensitivity, resulting in partial or complete
responses in vast majority of cases. Unfortunately, although many
patients can be rendered free of clinical evidence of disease, most
quickly relapse and die from this malignancy.
    Like all other lung cancers, SCLC is linked to a variety of
environmental risk factors. By for the strongest association is with the
use of tobacco: Up to 98% of SCLC patients have a history of smoking.
Occupational risks for SCLC include exposure to bischloromethyl
ethers, nickel, vinyl chloride, asbestos, cadmium, and radon daughters
(in uranium miners). Other types of radiation exposure also appear to be
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significant risk factors, with an increased incidence of SCLC in atomic
bomb survivors and patients (typically those with breast cancer or
Hodgkin’s lymphoma) exposed to therapeutic irradiation.
OTHER RELATED STUDIES
              The study done by Shi-Chuan Chang, MD, Reury-Perng Perng,
MD, PhD on “The Role of Fiberoptic Bronchoscopy in Evaluating
the Causes of Pleural Effusions” says, Fiberoptic bronchoscopy is
seemed to be justified in the diagnostic work-up of pleural effusions of
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unknown origin, since neoplasm is frequently the cause of a pleural
effusion that remains undiagnosed after analysis of pleural fluid and
closed pleural biopsy (1,2,3). On conclusion of this study, For patients
with unknown pleural effusions, Fiberoptic bronchoscopy was more
likely to yield a diagnosis than thoracentesis with closed pleural biopsy
in those who had hemoptysis or pulmonary abnormality on chest x-ray
films, whereas the reverse applied when these features were absent.
(Arch Intern Med 1989;Vol-149;855-857).
The study done by R H Poe, P C Levy, R H Israel, C R Oritz
and M C Kallay on “Use of fiberoptic bronchoscopy in the diagnosis
of bronchogenic carcinoma. A study in patients with idiopathic
pleural effusions.” says Fiberoptic bronchoscopy is justified in patients
with malignant effusion and no obvious primary tumor, since up to one
third of malignant pleural disease is due to bronchogenic carcinoma
(29). They concluded that Fiberoptic bronchoscopy is likely to be
helpful and should be done when an isolated effusion is large, in
which case the yield approaches that found for patients who presents
with hemoptysis or who have infiltrates on chest x-ray films.
(CHEST 1994;VOL-105;1663-1667).
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The study done by Kim CH, Son JW, Kim GY, Kim JS, Chae
SC, Hee J,Kim YJ, Park JY, Jung TH on “The Role of Bronchoscopy
in Determining the Etiology of Pleural Effusion” had the following
results, In 25 cases with unknown etiology after pleural biopsy,
additional diagnostic yield by bronchoscopy was 36%(4/11) in patients
with associated features and only 7%(1/14) with lone effusion, and, as
the sole mean for diagnosis in all patients with pleural effusion, was
only 4.5%(5/12). They concluded that, in a region of high prevalence of
TB as a cause of pleural effusion, pleural biopsy is more effective
method when invasive method is required for confirmative diagnosis of
unexplained exudative pleural effusion, and bronchoscopy is unlikely to
aid in the diagnosis of lone pleural effusion.(Tuberc Respir Dis 1998
Apr 45(2):397-403.)
The study done by Heaton RW, Roberts CM on “The Role of
Fiberoptic bronchoscopy in the investigation of Pleural effusion”
reviewed the case records of 32 patients who had bronchoscopy for
undiagnosed pleural effusion, in only 6 patients FOB yielded a diagnosis
and in 4 of these the diagnosis was also established by less invasive
means. The other 2 had radiographic abnormalities suggestive
of bronchial neoplasm. In conclusion of the study, FOB
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should be performed only in those patients who have
independent clinical evidence suggestive of a bronchial carcinoma.
(Postgrad Med  J 1988;Vol-64:581-2.[IV]).
The review article by, Marios E.Froudarakis on “Diagnostic
Work-up of Pleural Effusions” says, when an endotracheal and/or
endobronchial lesion is suspected, FOB is indicated (30). After initial
work up, pleural effusion of unknown origin is associated with
bronchogenic carcinoma in more than 30% of the cases(30,31,32).
Also FOB is useful in assessing the extent of the disease
in tracheobronchial tree, which is important for treatment and
 prognosis. (30)
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MATERIALS AND METHODS
STUDY DESIGN
This is a Prospective (Observational) study designed to evaluate
the role of Fiberoptic bronchoscopy in evaluating causes of undiagnosed
pleural effusion.
STUDY CENTER
The study was done at the Department of Thoracic Medicine -
Rajiv Gandhi Government General Hospital, Chennai.
STUDY DURATION
January 2011 to September 2011
STUDY POPULATION
Patients with diagnosis of pleural effusion in more than 14 years
of age.
Proforma was designed and ethical clearance was obtained.
A written informed consent was obtained from all the patients included
in the study after explaining in detail the nature and purpose of
the study.
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INCLUSION CRITERIA
Individuals of more than 14 years of age with diagnosis of pleural
effusion.
EXCLUSION CRITERIA
Refractory hypoxemia
Bleeding diathesis
Un co-operative patients
Patients not willing for scopy
Cardiac, Renal, and Liver diseases
STUDY PROCEDURE
Patients with the diagnosis of pleural effusion, fulfilling inclusion
criteria were admitted in Thoracic Medicine Ward at Rajiv Gandhi
Government General Hospital.
Routine blood investigations, Chest skiagram, Sputum for Acid
Fast Bacillus, Mantoux test and Pleural fluid analysis were done for all
patients.
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Pleural fluid was sent for biochemical, microbiological, and
cytological analysis.
      Informed and written consents were obtained from the patient.
For patients with exudative Pleural effusion to whom initial
investigations were inconclusive, pleural biopsy and Fiberoptic
bronchoscopy were done under strict aseptic precaution under local
anaesthesia and specimen were sent for biochemical, microbiological,
cytological and histopathological analysis.
METHOD OF FIBEROPTIC BRONCHOSCOPY
Having determined the indication for bronchoscopy, patient was
advised to be in nil oral for 4-6 hours on the day of procedure. Patient’s
consent was obtained and premedicated with intramuscular
Glycopyrrolate injection to reduce the secretions in the airways and to
diminish the chance of vasovagal phenomena such as
bronchoconstriction and bradycardia. About 30 minutes after
premedication the patient was transferred to a couch, made flat, and
supported by two pillows only. Topical anaesthesia was given by three
methods. First, 4% lidocaine solution was sprayed directly into the
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patient’s mouth in the direction of the fauces. Second, To further
anaesthetize the cords and upper respiratory tract with about 5 mL of 4%
lidocaine solution given by transcutaneous cricothyroid injection. Third,
nasal mucosa was anaesthetized with 2% lidocaine gel containing
20mg/mL, 5mL was applied directly from the tube into each nostril.
Having anaesthetized the upper respiratory tract, the shaft of the
bronchoscope was well lubricated with 2% lidocaine gel and was
advanced into a nostril under direct vision. FOB was passed along the
floor of the nose. When the nasal approach was too narrow to permit the
bronchoscope to pass, patient was asked to hold a bite block between the
teeth or gums and the scope was introduced through oropharynx. As the
bronchoscope was advanced, the tip was flexed downwards and
epiglottis and larynx came into view. The position and movement of the
vocal cords with respiration was noted and vocal cord paralysis
confirmed or excluded.
         The tip of the bronchoscope was centered with regard to the vocal
cords and quickly advanced through the opening during inspiration.
Additional 2.5mL aliquots of 2% lidocaine instilled down the suction
channel of the bronchoscope, using boluses from 5 mL syringes made
up to volume with air in order to allow for the bronchoscope and to
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rapidly empty all the local anaesthetic from its channel. After passing
through the vocal cords further lidocaine was given through the suction
channel as 2% solution. The local anaesthetic action of lidocaine is
about 20 minutes and allowance of a safety margin of 1 hour after
bronchoscopy is quite long enough, for advising patient to have liquids
initially.
Once the carina reached, 2% lidocaine solution was given before
entering the major bronchi. Both bronchial tree were thoroughly
examined, when intraluminal lesion was found, bronchial wash and
bronchoscopic lung biopsy was done whichever was required.
Bronchoscopic lung biopsy was preferably done as the last procedure to
minimize the cough after biopsy by avoiding subsequent
instrumentation that frequently results in cough, thereby reducing the
risk of pneumothorax resulting from cough-induced barotrauma.
While taking biopsy, bronchoscope was advanced as far distally
as possible, with repeated application of topical anaesthetic as needed to
suppress cough. The bronchoscope was then maintained in the wedged
position while the biopsy forceps was inserted into the working channel
of the scope. After the distal end of the biopsy forceps exited the distal
end of the scope, the forceps was further advanced distally until its tip
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was beyond bronchoscopic visualization. The biopsy forceps was
opened 5-6 mm proximal to the area to be biopsied, advanced to the
lesion and then closed. At this point, the patient was asked if any pain
was experienced. If the patient indicated pain, the forceps was opened
and withdrawn without obtaining biopsy. The biopsy was then
attempted in another area.
During withdrawal of the forceps, the bronchoscope was
maintained in the wedged position (33,34). Two advantages of this
“wedge” technique: one, it maintains the tip of bronchoscope in the
optimal position so that more biopsies can be obtained without having to
withdraw the bronchoscope to clean the objective lens. Second, if post
biopsy bleeding occurs, the wedged position of the bronchoscope limits
the bleeding to the biopsied segment or subsegment of the lung.
After the biopsy was completed and the lack of bleeding was
confirmed, the bronchoscope was withdrawn proximally and the patient
was instructed to cough gently to see if this induces further bleeding.
When no further bleeding was observed, the bronchoscopy was fully
withdrawn from the airways to terminate the procedure. The obtained
biopsy specimen was sent for microbiological and histopathological
examination.
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RESULTS
We included 110 pleural effusion patients in our study. With
initial work up, diagnosis was made in 43(39.09%) patients. In the
remaining 67 patients, 3 patients were not willing for bronchoscopy.
Bronchoscopy and Pleural biopsy were done in 64 patients. Out of 64
patients whose diagnosis was not made by initial work up, FOB was
useful in making diagnosis in 18 (28.1%) cases. Pleural biopsy helped
in diagnosing 26 (40.62%) cases. The results from bronchoscopy and
pleural biopsy were analyzed and the results of which were as follows.
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AGE & SEX DISTRIBUTION
   YEARS      14-25 yrs     26-50 yrs      > 50 yrs
    MALE             3           8           27
  FEMALE             -          10           16
During the study period of  9 months, Pleural biopsy and
Fiberoptic bronchoscopy were done in 64 patients [ 38 males, 26
females] in whom initial diagnostic work up was inconclusive. There
was clear male predominance with the incidence more in elder age
group, relatively lower in middle age and very low incidence in younger
age group.
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DIAGNOSIS FROM INITIAL WORK UP
             After initial work up [chest skiagram, sputum for AFB, mantoux
test, pleural fluid analysis] of pleural effusion in 110 patients, diagnosis
was able to make up in 43 patients. Transudative effusion was most
commonly diagnosed in 20 patients, followed by tuberculosis (sputum
AFB +ve) in 10 patients. Cytology positive for malignant cells and
parapneumonic effusion each seen in 5 patients. Pancreatitis was
diagnosed in 2 patients and Lymphoma in one patient. Out of 110
patients, initial work up (Chest skiagram, Sputum AFB, Mantoux test,
Pleural fluid analysis) itself was able to diagnose in 43 (39.09%)
patients.
DIAGNOSIS  FROM  INITIAL WORK UP
Diagnosis         No  of  cases
Transudative effusion                20
Sputum AFB +ve                10
Cytology +ve for  malignant cells                 5
Lymphoma                1
Pancreatitis                2
Parapneumonic effusion                5
             Total               43 (39.09%)
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DIAGNOSIS  FROM  INITIAL  WORK  UP
This Pie chart shows the distribution of diagnosis made after initial work
up. Most common diagnosis made was Transudative pleural effusion
followed by Pulmonary Tuberculosis and then by Malignancy and
Parapneumonic effusion.
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STUDY  POPULATION  (n-110)
Diagnosis established by  initial work up          43
Underwent bronchoscopy and pleural biopsy          64
Patients not willing for bronchoscopy            3
       TOTAL          110
Total Study population  in our study was 110 patients. With Initial
work up, diagnosis was made in 43 (39.09%) patients. In the remaining
67 patients, 3 patients were not willing for bronchoscopy. Bronchoscopy
was done in 64 patients, where as Pleural Biopsy was done in 54
patients. Pleural Biopsy was not done in 10 patients in whom initial
work up was inconclusive, because of  minimal plural effusion.
PLEURAL BIOPSY
Out of 67 patients in whom initial work up was inconclusive,
Pleural biopsy was done in 54 patients after obtaining informed written
consent. Pleural biopsy was not done in rest of patients because of
minimal pleural effusion. Pleural biopsy was diagnostic in 26 (40.62%)
patients. Most common diagnosis made was Tuberculosis in 18 patients
followed by Adenocarcinoma in 5 patients, and then by Metastatic
carcinoma, Squamous cell carcinoma, and Small cell carcinoma each in
one patient.
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PLEURAL   BIOPSY
DIAGNOSIS NUMBER
TUBERCULOSIS              18
METASTATIC CARCINOMA                1
ADENOCARCINOMA                5
SQUAMOUS CELL CARCINOMA                1
SMALL CELL CARCINOMA                1
TOTAL               26 (40.62%)
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FOB  OBSERVATIONS  AND  RESULTS
Out of 67 patients in whom initial work up was inconclusive,
3 patients were not willing for Bronchoscopy. FOB was done in rest of
64 patients after obtaining informed written consent. Findings observed
in bronchoscopy were Erythema, Nodularity/Sessile lesion, Polypoidal
lesion, External compression. FOB was normal in 25 patients. Erythema
was seen in 5 patients, but none of them show positive results.
Nodularity/Sessile lesion was seen in 16 patients, out of them 10
patients showed positive results. In those 10 patients, 9 were diagnosed
as Malignancy and 1 as Endobronchial Tuberculosis. Polypoidal lesion
was seen in 5 patients, all of them showed positive results as
Malignancy. External compression was seen in 13 patients, out of them
3 patients showed positive results as Endobronchial Tuberculosis.
Totally, FOB was able to diagnose 18 cases (28.1%) out of 64 patients
in whom initial work up was inconclusive.
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FOB  OBSERVATIONS  AND  RESULTS
Findings Number Positive results
Normal 25 0
Erythema 5 0
Nodularity/sessile       lesion 16 10
Poly poidal  growth 5 5
External    compression 13 3
Total 64 18( 28.1%)
  FOB OBSERVATIONS AND RESULTS
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SUBTYPES  OF  MALIGNANCY
Out of 18 cases that were diagnosed from FOB, 14 cases
diagnosed as Malignancy and 4 cases as Endobronchial Tuberculosis. In
Malignancy, Squamous cell carcinoma was most commonly diagnosed
in 6 cases, followed by Small cell carcinoma in 5 cases, and then by
Adenocarcinoma in 3 cases.
Type Number
Squamous cell Carcinoma              6
Small cell carcinoma              5
Adenocarcinoma              3
Total             14
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RESULTS BRONCHOSCOPY AS PER AGE
DISTRIBUTION
We analyzed the bronchoscopy results based on age distribution
in our study. In patients of more than 50 years age group, bronchoscopy
is diagnostic in 13 patients out of 43 patients. Out of them 12 patients
were diagnosed as malignancy and one patient as Tuberculosis. In
patients of below 50 years age group, bronchoscopy is diagnostic in 5
patients out of 18 patients. Out of them 2 patients were diagnosed as
malignancy and 3 patients as Tuberculosis.
Age [in yrs]
Bronchoscopy
TotalNon-diagnostic Diagnostic
< or = 25 3 0 3
26-50 13 5 18
>50 30 13 43
Total 46 18 64
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RESULTS OF FIBEROPTIC BRONCHOSCOPY AS PER AGE
DISTRIBUTION
RESULTS OF BRONCHOSCOPY AND PLEURAL FLUID
EXAMINATION IN PATIENTS CLASSIFIED BY HEMOPTYSIS
We analyzed the study patients in whom initial work up was
inconclusive, based on clinical history of hemoptysis. Hemoptysis was
present in 26 patients and absent in 38 patients. The yield from
Bronchoscopy was more in patients with hemoptysis. The yield from
Pleural fluid examination was more in patients who had no hemoptysis.
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RESULTS OF BRONCHOSCOPY AND PLEURAL FLUID
EXAMINATION IN PATIENTS CLASSIFIED BY HEMOPTYSIS.
Hemoptysis No
Br. Wash
(or)
Biospy
Pleural fluid
examination
P- Value Test
Present  26 13 8 0.000<0.05 Student
t testAbsent 38 5 18 0.000 < 0.05
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RESULTS OF BRONCHOSCOPY AND PLEURAL FLUID
EXAMINATION IN PATIENTS CLASSIFIED BY
RADIOLOGIC PATTERN
Apart from hemoptysis we also analyzed the study patients based
on radiologic pattern, as those who presented only with pleural effusion
in 42 patients, and those with pleural effusion and parenchymal
abnormality in 22 patients. The yield from Bronchoscopy was more in
patients who presented with both Pleural effusion and Parenchymal
abnormality. The yield from Pleural fluid examination was more in
patients who presented only with Pleural effusion.
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RESULTS OF BRONCHOSCOPY AND PLEURAL FLUID
EXAMINATION IN PATIENTS CLASSIFIED BY RADIOLOGIC
PATTERN
Radiologic
Pattern
No
Br. Wash
(or)
Biospy
Pleural fluid
examination
P- Value Test
Only  Pleural
effusion
42 4 19 0.000<0.05
Student
t test
Pleural
Effusion +
Parenchymal
Abnormality
22 14 7 0.000 < 0.05
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DISCUSSION
In 19 to 25% of patients, the cause of pleural effusion remains
unexplained after pleural fluid analysis and pleural biopsy (35,36).
Fiberoptic Bronchoscopy is a useful tool in these patients of unexplained
pleural effusion.
           Chang et al (28) performed Bronchoscopy, Thoracentesis and
Pleural biopsy on 140 consecutive patients with pleural effusion. In the
patient group with an isolated pleural effusion, with no hemoptysis or
pulmonary abnormality on the chest radiograph, the yield from
bronchoscopy was 16% whereas pleural investigation yielded a positive
diagnosis in 61%. In the patient group of pleural effusion with
hemoptysis or pulmonary abnormality, the yield from bronchoscopy was
more than 70% whereas the yield from pleural investigation was less
than 35%.
          Williams et al (37) evaluated the role of FOB in 28 patients with
pleural effusion of undetermined etiology. In this group, 4 patients had a
diagnostic FOB, 3 for malignancy and one for tuberculosis. They
concluded that FOB was of value in the evaluation of patients with
undiagnosed pleural effusion.
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In our study, Out of 64 patients whose diagnosis was not made
by  initial work up, FOB was useful in making diagnosis in 18 (28.1%)
cases (p value- 0.000<0.005). Pleural biopsy helped in diagnosing 26
(40.62%) cases (p value- 0.000<0.005).
Pleural biopsy is particularly important for diagnosing
tuberculosis but will also slightly increase the yield for malignancy
(38,39,40).
For patients with exudative effusion still undiagnosed after
pleural fluid examination and with parenchymal abnormalities on chest
radiograph or with hemoptysis,  Fiberoptic  bronchoscopy is a useful
next step (28).
When combining Initial work up, Pleural biopsy, and Fiberoptic
Bronchoscopy in our study, 87 patients (79.09%) were diagnosed out of
110 patients.
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CONCLUSION
1. Pleural effusion of unknown origin both hemorrhagic and non-
hemorrhagic, are frequently encountered in tertiary care centre even
after completion of  exhaustive work-up.
2. Fiberoptic bronchoscopy is useful in the diagnosis of pleural
effusion, where at the end of usual diagnostic work-up, no etilogical
diagnosis was arrived at.
3. In pleural effusion of unknown origin especially in the more than 50
years age group, the contribution of Fiberoptic bronchoscopy in
reaching a diagnosis of malignancy is significant.
4. In below 50 years age group with undiagnosed pleural effusion, the
contribution of Fiberoptic bronchoscopy in diagnosing non malignant
causes like Tuberculosis is significant.
5. Hence, In patients with exudative pleural effusion still undiagnosed
after pleural fluid cytology and with parenchymal abnormalities on
chest skiagram or with history of hemoptysis, Fiberoptic
bronchoscopy is a useful procedure for arriving at a diagnosis
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INFORMATION SHEET
We are conducting a prospective study of “The Role of Fiberoptic
bronochoscopy in evaluating the causes of undiagnosed pleural effusion” at
Department of Thoracic Medicine, Madras Medical College and Rajiv
Gandhi Government General Hospital, Chennai.
The purpose of the study is to evaluate the diagnostic merit of fiberoptic
bronchoscopy in evaluating the causes of pleural effusion.
The privacy of the patients in the research will be maintained throughout the
study. In the event of any publication or presentation resulting from the
research, no personally identifiable information will be shared.
Taking part in this study is voluntary. You are free to decide whether to
participate in this study or to withdraw at any time; your decision will not
result in any loss of benefits to which you are otherwise entitled.
The results of the special study may be intimated to you at the end of the
study period or during the study if anything is found abnormal which may
aid in the management or treatment.
Signature of investigator Signature of participant
Date:
PATIENT CONSENT FORM
Study Details :  "The Role of  Fiberoptic bronochoscopy in evaluating the
causes of undiagnosed  pleural effusion”  at
Madras Medical College and Rajiv Gandhi Government
General Hospital, Chennai
Study Centre :   Department of Thoracic Medicine,
Madras Medical College, Chennai.
Patient may check ( ) these boxes
I confirm that I have understood the purpose of procedure for the above
study. I have the opportunity to ask question and all my questions and
doubts have been answered to my complete satisfaction.
I understand that my participation in the study is voluntary and that I am
free to withdraw at any time without giving reason, without my legal rights
being affected.
I understand that sponsor of the clinical study, others working on the
sponsor's behalf, the ethical committee and the regulatory authorities will
not  need  my  permission  to  look  at  my  health  records,  both  in  respect  of
current study and any further research that may be conducted in relation to
it, even if I withdraw from the study I agree to this access. However, I
understand that my identity will not be revealed in any information released
to third parties or published, unless as required under the law. I agree not to
restrict the use of any data or results that arise from this study.
I agree to take part in the above study and to comply with the instructions
given during the study and faithfully cooperate with the study team and to
immediately inform the study staff if I suffer from any deterioration in my
health or well being or any unexpected or unusual symptoms.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including hematological, biochemical, radiological tests.
I hereby consent to participate in this study.
Signature/ Thumb Impression:
Patient Name and Address: Place Date
Signature of Investigator
Study Investigator's Name: Place Date
PROFORMA
Name of the Patient :
Age : Sex : Date :
Presenting Complaints :
Cough with Expectoration
Chest Pain
Breathlessness
Fever
Loss of  Weight
Loss of Appetite
Difficulty in Swallowing
Hoarseness  of Voice
Past H/O
H/o Prior ATT / Contact with TB
H/o DM / Hypertension / CAD
Personal  H/O
H/O Smoking
H/O Alcoholism
Investigations :
i. Chest x ray findings
ii. Mantoux Test
iii. Sputum AFB results
iv. Complete Blood Count
v. Renal Function tests
vi. Liver Function tests
Pleural Fluid Analysis:
i. Sugar
Protein
LDH
ii. AFB
iii. Cytology
iv. Cell Count
v. NT C/S
Pleural Biopsy
Bronchoscopy Findings :
Bronchial Wash:
i. Cytology
ii. AFB
iii. NT C/S
iv. Cell Count
v. Fungal Smear
Bronchial Biopsy :
